Register Login

Taysha Gene Therapies (TSHA)

Alam Kamran 🟢 acquired 590.0K shares (1 derivative) of Taysha Gene Therapies, Inc. (TSHA) at $4.86 ($1.1M) Transaction Date: Jan 12, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 2:23 p.m.

    🔍 Alam Kamran (Executive)

    Company: Taysha Gene Therapies, Inc. (TSHA)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 590,000

    Detailed Transactions and Holdings:

    • Acquired 359,000 shares of Common Stock (Direct)
      Date: 2026-01-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,546,603.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 231,000 shares of Employee Stock Option (right to buy) at $4.86 per share (Derivative)
      Date: 2026-01-12 | Code: A | Expires: 2036-01-12 | equity_swap_involved: 0 | shares_owned_after: 231,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
    • F2: 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Search

News categories